Commercialization and Medical Affairs expenses (excluding stock-based compensation)
Mirum Pharmaceuticals, Inc.·Business Segments·1 segment
Breakdown
Segments
Business SegmentsView metric
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Business Segments | $35.78M | $39.59M | $36.6M | $44.05M | $44.22M |
| Total | $35.78M | $39.59M | $36.6M | $44.05M | $44.22M |